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Renal Cell Carcinoma
Jose Araujo1, Luigi Perelli2 & Giannicola Genovese2,3
1Partnership

for Careers in Cancer Science and Medicine, Department of Faculty Diversity, Equity, & Inclusion, The University of Texas MD
Anderson Cancer Center, Houston, Texas 77030
2Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, 77030
3Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, 77030

Introduction

•

•

•

Eukaryotic systems precisely and efficiently
cope to environmental stressors. Among
these, adaptation to the variation of oxygen
levels (Hypoxia/Hyperoxia) is essential for
survival.
Genetic alterations of the hypoxia response
pathway are common drivers of clear cell
renal cell carcinoma (ccRCC). On the other
hand, non-clear cell renal cell carcinoma
(nccRCC) usually display an intact response
to the hypoxia stress pathway.
Understanding how different genomic driven
Renal Cancers survive under hypoxic stress
is of extreme importance for the
understanding of Renal Cancer evolution

Hypothesis: nccRCC tumor models possess
unique abilities to survive and adapt to hypoxia
and therefore will show phenotypic differences
in terms of viability and stem cells
characteristics.
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Experimental
design of the generation
of GEMM derived tumor
organoids. This system
allows for the rapid
generation of somatic
mosaic
alterations
commonly observed in
human nccRCC and,
thus,
a
reliable
experimental
model
mirroring
patients’
disease progression

Generation and propagation of tumor
organoids in vitro
• Kidney tumor organoids were plated
into a 12 well plate in 40ul of Cultrex
per each well and supplemented with
.
1mL of DMEM/F12 Medium containing
10% FBS and 1% PS.
•

•

Figure 1. Schematic showing possible effects of hypoxia on growth of
nccRCC models. Created by BioRender.com

•

Methods

•

GEM model of metastatic nccRCC
Tumor explants were derived from a
metastatic model of nccRCC. Briefly, 4-6
weeks old Pax8Cre, H11lsl-spCas9, R26lsl-fsftdTomato mice received renal subcapsular
injection of 109 AAV viral particles, carrying
sgRNA for the knockout of known genetic
drivers of nccRCC (Nf2, Setd2, Cdkn2a,
Cdkn2b) and a conditional FLEX-Flpo system
for the tissue-specific activation of the
Tdtomato fluorescent reporter. At terminal
disease, mice were euthanized, and tumor
cell lines were extracted from primary tumors
and cultured in 3D as organoids

•

Organoids
were
passaged
by
aspirating the medium from the wells
and adding 1mL of ice-cold PBS to
each well in order to disaggregate
organoids from Cultrex. Organoids
were, then, centrifuged for 5 minutes at
150g; the pelleted organoids were
dissociated with Trypsin incubation of
5’ at 37C 5%CO2. Single cell
suspensions were plated as previously
described with a concentration of 5,000
cells/40ul of Cultrex..

Discussion

Results

• nccRCC
tumor
organoids
were
successfully generated and propagated
in vitro.
• Organoids
showed
different
morphology and sizes, suggesting
phenotypical tumor heterogeneity.
• Analysis of organoid size and number
showed a statistically significant
difference between tumor organoids
under the effect of normoxic but not
under the effect hypoxic environment.
A) Normoxia

• Following data analysis, we observed that
there was a statistically significant (p <
0.05) difference in the number of
organoids in the plate that went into
normoxia at 0 hours compared to 72 hours
while no differences have been observed
in hypoxia, suggesting that hypoxic
conditions have a negative impact on
stemness capabilities of nccRCC.
• Likewise, the size of organoids in
normoxia showed statistical significance
(p<0.01) between the 0 hour and 72 hour
time points, while no differences have
been observed in hypoxic condition. These
data suggest that hypoxia severely impact
tumor organoids proliferation.
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Given our data, it can be understood that
nccRCC cells have a sensitivity to low
oxygen levels which prevents cell
proliferation from occurring therefore rely on
a specific oxygen level to proliferate. This
suggests that low oxygen levels are not
always the cause for uncontrollable tumor
growth in renal cell cancer.

Future Works

C)

Data Quantification
Three days after organoid plating, two
different plates were incubated at 37C,
5% CO2 in normoxic conditions (21%
oxygen) or severe hypoxic conditions
(1% oxygen) for 72 hours.

The vulnerability of nccRCC cells to hypoxia
can be used to find new therapeutic methods
to reduce the severity of this type of kidney
cancer. A longer experiment (i.e 7 days) can
be done in the future to further confirm the
effects of hypoxia in nccRCC cells.

Images of tumor organoids were
collected at time 0 (immediately before
hypoxia or normoxia treatment) and 72
hours after hypoxia or normoxia
treatment. Fields were randomly
selected at 40X magnification.
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D) Size of Organoids

Data analysis was performed with
ImageJ software FIJI and statistical
analysis with GraphPad Prism 9

Figure 3. Experimental design for testing hypoxia effects on
nccRCC organoids. One plate was incubated in normoxia (21%
oxygen) and another plate was incubated in hypoxia (1%
oxygen) for 72 hours each. Created by BioRender.
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Figure 4. A) Three pictures showing organoids exposed to
normoxia with bright field, tdTomato, and merged channels at
40x magnification. B) Three pictures depicting organoids after
being exposed to hypoxia at 40x magnification on different
channels. C) Box and whiskers plot comparing the number of
organoids at the beginning and end of the experiment (Normx
0hr; N= 113, Normx 72hr; N= 178, Hypox 0hr; N = 81, Hypox
72h; N=130). D) Violin plot comparing the size of organoids
before and after normoxia and hypoxia (N=33; N=56; N=33;
N56) *, p value < 0.05; **, p value < 0.01
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